$36.01
0.77% yesterday
Nasdaq, Nov 25, 10:15 pm CET
ISIN
US30233M1071
Symbol
EYEG
Sector
Industry

EyeGate Pharmaceuticals, Inc. Stock price

$36.09
+0.11 0.31% 1M
+0.83 2.34% 6M
+0.09 0.25% YTD
+35.58 7,004.33% 1Y
-24.31 40.25% 3Y
-236.71 86.77% 5Y
-3,503.91 98.98% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.36 0.99%
ISIN
US30233M1071
Symbol
EYEG
Sector
Industry

Key metrics

Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-9.35m
Free Cash Flow (TTM) Free Cash Flow $-9.10m
Cash position $5.40m
EPS (TTM) EPS $-4.07
Short interest 11.48%

Is EyeGate Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Financial data from EyeGate Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '23
+/-
%
- -
-
100%
- Direct Costs 0.15 0.15
25% 25%
-
-0.15 -0.15
25% 25%
-
- Selling and Administrative Expenses 5.29 5.29
28% 28%
-
- Research and Development Expense 3.76 3.76
4% 4%
-
-9.20 -9.20
18% 18%
-
- Depreciation and Amortization 0.15 0.15
25% 25%
-
EBIT (Operating Income) EBIT -9.35 -9.35
18% 18%
-
Net Profit -13 -13
24% 24%
-

In millions USD.

Don't miss a Thing! We will send you all news about EyeGate Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Head office United States
CEO Brian Strem
Founded 1998
Website www.kiorapharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today